Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Styczynski

Showing results (91-100 of 155) with videos related to

Pageof 16
Sort By:
Scientific Reports|November 2, 2021
The urinary excretion of epigenetically modified DNA as a marker of pediatric ALL status and chemotherapy responseRafal Rozalski, Daniel Gackowski, Aleksandra Skalska-Bugala, et al.
British Journal of Clinical Pharmacology|November 20, 2024
Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children: A substudy of 2 phase 2 trialsKrzysztof Kalwak, Ajay Vora, Peter Bader, et al.
The Lancet. Infectious Diseases|April 20, 2026
Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry studyAnnalisa Paviglianiti, Per Ljungman, Rafael de la Camara, et al.
Infection and Drug Resistance|June 20, 2019
Infectious complications in children with malignant bone tumors: a multicenter nationwide studyKrzysztof Czyzewski, Przemyslaw Galazka, Patrycja Zalas-Wiecek, et al.
Leukemia|April 29, 2022
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)Simone Cesaro, Per Ljungman, Malgorzata Mikulska, et al.
Bone Marrow Transplantation|May 15, 2020
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapyPer Ljungman, Malgorzata Mikulska, Rafael de la Camara, et al.
Leukemia & Lymphoma|October 21, 2016
Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemiaMarcin Braun, Agata Pastorczak, Wojciech Fendler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 27, 2018
Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow TransplantationSimone Cesaro, Gloria Tridello, Nicole Blijlevens, et al.
Hematology/Oncology and Stem Cell Therapy|August 4, 2020
The Risk and Prognosis of COVID-19 Infection in Cancer Patients: A Systematic Review and Meta-AnalysisGhada M ElGohary, Shahrukh Hashmi, Jan Styczynski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 16, 2009
Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective studySimone Cesaro, Hans H Hirsch, Maura Faraci, et al.
Pageof 16

Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Scientific Reports|November 2, 2021
The urinary excretion of epigenetically modified DNA as a marker of pediatric ALL status and chemotherapy responseRafal Rozalski, Daniel Gackowski, Aleksandra Skalska-Bugala, et al.
British Journal of Clinical Pharmacology|November 20, 2024
Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children: A substudy of 2 phase 2 trialsKrzysztof Kalwak, Ajay Vora, Peter Bader, et al.
The Lancet. Infectious Diseases|April 20, 2026
Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry studyAnnalisa Paviglianiti, Per Ljungman, Rafael de la Camara, et al.
Infection and Drug Resistance|June 20, 2019
Infectious complications in children with malignant bone tumors: a multicenter nationwide studyKrzysztof Czyzewski, Przemyslaw Galazka, Patrycja Zalas-Wiecek, et al.
Leukemia|April 29, 2022
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)Simone Cesaro, Per Ljungman, Malgorzata Mikulska, et al.
Bone Marrow Transplantation|May 15, 2020
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapyPer Ljungman, Malgorzata Mikulska, Rafael de la Camara, et al.
Leukemia & Lymphoma|October 21, 2016
Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemiaMarcin Braun, Agata Pastorczak, Wojciech Fendler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 27, 2018
Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow TransplantationSimone Cesaro, Gloria Tridello, Nicole Blijlevens, et al.
Hematology/Oncology and Stem Cell Therapy|August 4, 2020
The Risk and Prognosis of COVID-19 Infection in Cancer Patients: A Systematic Review and Meta-AnalysisGhada M ElGohary, Shahrukh Hashmi, Jan Styczynski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 16, 2009
Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective studySimone Cesaro, Hans H Hirsch, Maura Faraci, et al.
Pageof 16